Amanda Zimmerman
Medical · Winston Salem, NCNPI 1265525497
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (39.5%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Averitas Pharma Inc. at 33.5% of the total. Reporting peaked in 2024 at $14,010 and has fallen 53.4% since, to $6,529 in 2025. Among medical clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 404 payments — averaging $119.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Averitas Pharma Inc.$16K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$11K
- GRT US Holding, Inc.$8K
- Saluda Medical Americas, Inc.$4K
- Biodelivery Sciences International, Inc.$3K
- Collegium Pharmaceutical, Inc.$2K
- plus $5K from 22 others
What the payments were for
- Consulting fees$10,51422%
- Speaking & faculty fees$19,00039%
- Travel & lodging$6,60414%
- Food & beverage$12,02125%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Averitas Pharma Inc. | 27 | $16,131 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 111 | $10,692 |
| GRT US Holding, Inc. | 19 | $7,610 |
| Saluda Medical Americas, Inc. | 22 | $3,701 |
| Biodelivery Sciences International, Inc. | 17 | $3,084 |
| Collegium Pharmaceutical, Inc. | 53 | $1,741 |
| Nevro Corp. | 18 | $1,208 |
| AbbVie | 37 | $675 |
| Vertex | 13 | $626 |
| Boston Scientific | 8 | $559 |
| SPR Therapeutics, Inc | 5 | $381 |
| Pfizer | 16 | $378 |
| Forte Bio-pharma LLC | 5 | $164 |
| Azurity Pharmaceuticals, Inc. | 7 | $135 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $118 |
| Globus Medical | 1 | $111 |
| Arbor Pharmaceuticals, Inc. | 5 | $101 |
| Axsome Therapeutics, Inc. | 3 | $97 |
| Redhill Biopharma Inc. | 5 | $95 |
| Tonix Medicines, Inc. | 1 | $94 |
| Biohaven Pharmaceuticals, Inc. | 5 | $81 |
| Nalu Medical, Inc. | 1 | $80 |
| Virtus Pharmaceuticals LLC | 4 | $77 |
| Scilex Pharmaceuticals Inc. | 5 | $74 |
| Almatica Pharma LLC | 4 | $52 |
| Medtronic | 2 | $39 |
| Painteq LLC | 1 | $22 |
| Hikma Pharmaceuticals USA | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$48,140 in reported general payments places this provider in the 95th percentile of 878 medical providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 404 | $361,999 |
| NucyntaTapentadol Hcl | 133 | $204,413 |
| Xtampza ErOxycodone Myristate | 346 | $200,386 |
| OxycontinOxycodone Hcl | 208 | $152,534 |
| RelistorMethylnaltrexone Bromide | 54 | $131,977 |
| Nucynta ErTapentadol Hcl | 62 | $116,902 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 2,000 | $78,323 |
| HorizantGabapentin Enacarbil | 63 | $69,034 |
| Buprenorphine | 206 | $55,282 |
| Levorphanol Tartrate | 17 | $48,255 |
| UbrelvyUbrogepant | 21 | $37,718 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,116 | $35,584 |
| Oxycodone Hcl | 1,411 | $30,449 |
| Nurtec OdtRimegepant Sulfate | 11 | $21,121 |
| Morphine Sulfate ErMorphine Sulfate | 579 | $18,911 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Nucynta, Xtampza Er, Nucynta Er | $1,741 | $883,701945 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $10,692 | $131,97754 claims |
| Arbor Pharmaceuticals, Inc.Horizant | $101 | $69,03463 claims |
| Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate | $16 | $60,374334 claims |
| AbbVieUbrelvy, Linzess | $675 | $50,37542 claims |
| Virtus Pharmaceuticals LLCLevorphanol Tartrate | $77 | $48,25517 claims |
| PfizerNurtec Odt | $378 | $21,12111 claims |
| Redhill Biopharma Inc.Movantik | $95 | $18,54943 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 878 medical providers in North Carolina.
Other medical in Winston Salem
- John RobbinsWinston Salem$26K
- Christopher GeorgeffWinston Salem$13K
- Victoria HinkelWinston Salem$12K
- Grace McLaurinHickory$553K
- Joel ThompsonCharlotte$265K
- Virginia JethroCary$213K
- Payal Soni-PatelAsheville$76K
- William JarrettElkin$59K
- David TaylorMorehead City$40K
- Katherine CardSalisbury$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.